Russell Investments Group Ltd. Buys New Holdings in Tempus AI, Inc. $TEM

Russell Investments Group Ltd. bought a new stake in shares of Tempus AI, Inc. (NASDAQ:TEM) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 5,381 shares of the company’s stock, valued at approximately $260,000.

Several other institutional investors also recently bought and sold shares of the stock. ARK Investment Management LLC boosted its holdings in Tempus AI by 35.9% during the 1st quarter. ARK Investment Management LLC now owns 7,501,399 shares of the company’s stock valued at $361,867,000 after acquiring an additional 1,981,755 shares during the period. Vanguard Group Inc. boosted its holdings in Tempus AI by 6,247.5% during the 1st quarter. Vanguard Group Inc. now owns 5,995,117 shares of the company’s stock valued at $289,204,000 after acquiring an additional 5,900,668 shares during the period. Nikko Asset Management Americas Inc. boosted its holdings in Tempus AI by 31.5% during the 1st quarter. Nikko Asset Management Americas Inc. now owns 4,260,553 shares of the company’s stock valued at $205,401,000 after acquiring an additional 1,021,460 shares during the period. Sumitomo Mitsui Trust Group Inc. boosted its holdings in Tempus AI by 31.4% during the 1st quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,255,477 shares of the company’s stock valued at $205,284,000 after acquiring an additional 1,016,384 shares during the period. Finally, Frontier Capital Management Co. LLC boosted its holdings in Tempus AI by 236.2% during the 4th quarter. Frontier Capital Management Co. LLC now owns 943,718 shares of the company’s stock valued at $31,860,000 after acquiring an additional 663,018 shares during the period. 24.22% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Tempus AI

In other news, CEO Eric P. Lefkofsky sold 332,500 shares of the stock in a transaction that occurred on Wednesday, August 27th. The stock was sold at an average price of $74.10, for a total value of $24,638,250.00. Following the completion of the transaction, the chief executive officer owned 9,207,533 shares of the company’s stock, valued at approximately $682,278,195.30. This represents a 3.49% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Ryan Fukushima sold 17,460 shares of the stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total value of $1,303,389.00. Following the completion of the transaction, the chief operating officer directly owned 839,180 shares of the company’s stock, valued at $62,644,787. This represents a 2.04% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 1,108,951 shares of company stock worth $77,660,938. 26.27% of the stock is owned by insiders.

Tempus AI Stock Up 3.0%

Shares of NASDAQ:TEM opened at $75.86 on Tuesday. Tempus AI, Inc. has a 52-week low of $31.36 and a 52-week high of $91.45. The firm has a market capitalization of $13.18 billion, a P/E ratio of -63.75 and a beta of 5.07. The stock has a 50 day moving average price of $64.51 and a 200-day moving average price of $59.07. The company has a debt-to-equity ratio of 2.58, a quick ratio of 1.43 and a current ratio of 1.54.

Tempus AI (NASDAQ:TEM) last announced its earnings results on Friday, August 8th. The company reported ($0.22) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.23) by $0.01. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.The firm had revenue of $314.64 million during the quarter, compared to analyst estimates of $296.84 million. During the same quarter in the prior year, the company earned ($6.86) EPS. The business’s revenue was up 89.5% compared to the same quarter last year. Tempus AI has set its FY 2025 guidance at EPS. As a group, equities research analysts anticipate that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts have commented on the company. Piper Sandler reaffirmed a “neutral” rating on shares of Tempus AI in a research report on Friday, August 8th. Morgan Stanley upped their price target on Tempus AI from $65.00 to $68.00 and gave the company an “overweight” rating in a research report on Tuesday, August 12th. BTIG Research upped their price target on Tempus AI from $75.00 to $85.00 and gave the company a “buy” rating in a research report on Wednesday, August 20th. Guggenheim upped their price target on Tempus AI from $65.00 to $75.00 and gave the company a “buy” rating in a research report on Monday, June 30th. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $70.00 price target on shares of Tempus AI in a research report on Friday, August 8th. Six research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $67.64.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.